This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cordes, S. P. Search for Related Content PubMed PubMed Citation Articles by Cordes, S. P.

 Previous Article  |  Next Article 

Microbiology and Molecular Biology Reviews, September 2005, p. 426-439, Vol. 69, No. 3
1092-2172/05/$08.00+0     doi:10.1128/MMBR.69.3.426-439.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

N-Ethyl-N-Nitrosourea Mutagenesis: Boarding the Mouse Mutant Express

Sabine P. Cordes^*

Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5, and Department of Medical and Molecular Genetics and Microbiology, University of Toronto, 1 King's Circle, Toronto, Ontario, Canada

In the mouse, random mutagenesis with N-ethyl-N-nitrosourea (ENU) has been used since the 1970s in forward mutagenesis screens. However, only in the last decade has ENU mutagenesis been harnessed to generate a myriad of new mouse mutations in large-scale genetic screens and focused, smaller efforts. The development of additional genetic tools, such as balancer chromosomes, refinements in genetic mapping strategies, and evolution of specialized assays, has allowed these screens to achieve new levels of sophistication. The impressive productivity of these screens has led to a deluge of mouse mutants that wait to be harnessed. Here the basic large- and small-scale strategies are described, as are the basics of screen design. Finally, and importantly, this review describes the mechanisms by which such mutants may be accessed now and in the future. Thus, this review should serve both as an overview of the power of forward mutagenesis in the mouse and as a resource for those interested in developing their own screens, adding onto existing efforts, or obtaining specific mouse mutants that have already been generated.

---

* Mailing address: Samuel Lunenfeld Research Institute, Room 865, Mt. Sinai Hospital, 600 University Ave., Toronto, Ontario M5G 1X5, Canada. Phone: (416) 586-8891. Fax: (416) 586-8588. E-mail: cordes{at}mshri.on.ca.

---

Microbiology and Molecular Biology Reviews, September 2005, p. 426-439, Vol. 69, No. 3
1092-2172/05/$08.00+0     doi:10.1128/MMBR.69.3.426-439.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Juan, T., Veniant, M. M., Helmering, J., Babij, P., Baker, D. M., Damore, M. A., Bass, M. B., Gyuris, T., Chhoa, M., Li, C.-M., Ebeling, C., Amato, J., Carlson, G. A., Lloyd, D. J. (2009). Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in mice. J. Lipid Res. 50: 534-545 [Abstract] [Full Text]  
• Smith, A P L, Polley, S, Wells, S, Stewart, M, Vizor, L, Humphreys, J, Warren, M V, Dear, N, Cheeseman, M T (2009). Analysis of breeding and pathology helps refine management practices of a large-scale N'-ethyl-N'-nitrosourea mouse mutagenesis programme. Lab Anim 43: 1-10 [Abstract] [Full Text]  
• Mallon, A.-M., Blake, A., Hancock, J. M. (2008). EuroPhenome and EMPReSS: online mouse phenotyping resource. Nucleic Acids Res 36: D715-D718 [Abstract] [Full Text]  
• Westrick, R. J., Winn, M. E., Eitzman, D. T. (2007). Murine Models of Vascular Thrombosis. Arterioscler. Thromb. Vasc. Bio. 27: 2079-2093 [Abstract] [Full Text]  
• Reue, K., Vergnes, L. (2006). Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Approaches to lipid metabolism gene identification and characterization in the postgenomic era. J. Lipid Res. 47: 1891-1907 [Abstract] [Full Text]